"Midwest Cornea Associates specialize in a variety of corneal transplantation techniques as well as LASIK, complex anterior segment and cataract surgery. All corneal diseases are treated including infections, dystrophies, degenerations and ocular surface diseases."

During the past decade, Midwest Cornea Associates, LLC conducted 10 clinical trials. In the 10-year time frame, 10 clinical trials started and 4 clinical trials were completed, i.e. on average, 40% percent of trials that started reached the finish line to date. In the past 5 years, 6 clinical trials started and 4 clinical trials were completed. i.e. 66.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Midwest Cornea Associates, LLC" #1 sponsor was "ReGenTree, LLC" with 2 trials, followed by "BRIM Biotechnology Inc." with 1 trials sponsored, "Claris Biotherapeutics, Inc." with 1 trials sponsored, "Formosa Pharmaceuticals, Inc." with 1 trials sponsored and "HanAll BioPharma Co., Ltd." with 1 trials sponsored. Other sponsors include -1 different institutions and companies that sponsored additional 9 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Midwest Cornea Associates, LLC" #1 collaborator was "Daewoong Pharmaceutical Co. LTD." with 1 trials as a collaborator and "ORA, Inc." with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Midwest Cornea Associates, LLC" are "Dry Eye" (3 trials), "Dry Eye Syndromes" (2 trials), "Bacterial Conjunctivitis" (1 trials), "Blepharitis" (1 trials) and "Dry Eye Syndrome" (1 trials). Many other conditions were trialed in "Midwest Cornea Associates, LLC" in a lesser frequency.

Most popular intervention types in "Midwest Cornea Associates, LLC" are "Drug" (8 trials) and "Biological" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (6 trials), "RGN-259" (2 trials), "0.005% Lacripep" (1 trials), "0.01% Lacripep" (1 trials) and "APP13007, 0.05%" (1 trials). Other intervention names were less common.

The vast majority of trials in "Midwest Cornea Associates, LLC" are 10 trials for "All" genders.

Currently, there are NaN active trials in "Midwest Cornea Associates, LLC". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 8 completed trials in Midwest Cornea Associates, LLC, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Midwest Cornea Associates, LLC, 2 "Phase 1" clinical trials were conducted, 4 "Phase 2" clinical trials and 8 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".